Search News

Corporate Industry Technology Medical Updates

Ventricular Assist Device

Corporate
TCT 2024 | NyokAssist® Makes Global Debut as a Novel Interventional Ventricular Assist Device 2024-11-01
Corporate
magAssist Presents MoyoAssist® at ESAO 2024, Advancing Global Dialogue in Artificial Organ Technology 2024-09-26
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi 2023-08-23
Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
FDA Grants "Breakthrough Device" Designation to magAssist's NyokAssist® Interventional Ventricular Assist Device 2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth 2023-07-28
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist, Founding Member of “Suzhou-Soochow Overseas Chinese Entrepreneurship and Innovation Alliance”, Facilitates Innovation and Entrepreneurship of Returned Students 2023-01-16

Tabs： membrane oxygenator, cardiac arrest, DonorLife Organ Care System, ECMO manufacturers, Fortune, left ventricular assist devices, multi-organ life support, Bridge-to-other destination therapy, Chronic heart failure, the new generation ECMO system,